CSB 2.001 CSB 2.001Addition of Methiopropamine to schedule I. Section 961.14 (7) (t), Stats., is created to read:
961.14 (7) (t) N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly known as Methiopropamine.
CSB 2.001 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-3-23.
CSB 2.002 CSB 2.002Excluding Fenfluramine from schedule IV. Section 961.20 (4) (am), Stats., is repealed.
CSB 2.002 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-17-23; correction made under s. 35.17, Stats., Register April 2023 No. 808.
CSB 2.003 CSB 2.003 Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.
CSB 2.003(1)(1) Section 961.20 (2) (ef), Stats., is repealed.
CSB 2.003(2) (2) Section 961.14 (5) (aa), (ab), (ac), (ad), and (ae), Stats., are created to read:
961.14 (5) (aa) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ab) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one).
(ac) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ad) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ae) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
CSB 2.003 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register September 2023 No. 813, eff. 9-25-23; correction in (2) made under s. 35.17, Stats., Register September 2023 No. 813.
CSB 2.004 CSB 2.004Addition of Zuranolone to Schedule IV. Section 961.20 (2) (r), Stats., is created to read:
961.20 (2) (r) Zuranolone.
CSB 2.004 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24; correction in numbering of CSB 2.004 made under s. 13.92 (4) (b) 1., Stats., Register February 2024 No. 818.
CSB 2.005 CSB 2.005Addition of 9 Fentanyl Related Substances to Schedule I.
CSB 2.005(1)(1)Section 961.14 (2) (nd) 3m., 10m., 11m., 12e., 12m., 12s., 16n., 17g., and 17r., are created to read:
961.14 (2) (nd) 3m. Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
10m. 2',5'-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
CSB 2.005 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.
CSB 2.006 CSB 2.006Adding 5 Synthetic Cannabinoids to Schedule I.
CSB 2.006(1)(1)Section 961.14 (4) (tb) 54. to 58., Stats., are created to read:
961.14 (4) (tb) 54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.
55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.
56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.
57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.
58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.
CSB 2.006 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.
APPENDIX
CSB 2.006 Note Note: This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.
CSB 2.006 Note CSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s. 161.16, Stats., schedule II in sub. (6) which subsection is hereby created.
CSB 2.006 Note Note: See Chapter 206, Laws of 1981 sections 29 and 31.
CSB 2.006 History History: Cr. Register, June, 1973, No. 210, eff. 7-1-73.
CSB 2.006 Note CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:
CSB 2.006 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.006 Note (a) Benzphetamine
CSB 2.006 Note (b) Chlorphentermine
CSB 2.006 Note (c) Clortermine
CSB 2.006 Note (d) Mazindol
CSB 2.006 Note (e) Phendimetrazine
CSB 2.006 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.006 Note CSB 2.03 Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to s. 161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:
CSB 2.006 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.006 Note (a) Fenfluramine:
CSB 2.006 Note Note: See Chapter 206, Laws of 1981 section 47.
CSB 2.006 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.006 Note CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows:
CSB 2.006 Note (7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
CSB 2.006 Note (a) Amobarbital
CSB 2.006 Note (b) Pentobarbital
CSB 2.006 Note (c) Secobarbital
CSB 2.006 Note (2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., schedule III, are hereby created to read as follows:
CSB 2.006 Note (m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CSB 2.006 Note (n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
CSB 2.006 Note Note: See Chapter 206, Laws of 1981 sections 30 and 37.
CSB 2.006 History History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.006 Note CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s. 161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
CSB 2.006 Note (hm) Drotebanol;
CSB 2.006 History History: Cr. Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.006 Note CSB 2.06 Addition of pentazocine to schedule III. Subsection (4m) of s. 161.18, Stats., schedule III is hereby created to read as follows:
CSB 2.006 Note (4m) Pentazocine.
CSB 2.006 Note Note: See Chapter 6, Laws of 1981 sections 2 and 3.
CSB 2.006 History History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.006 Note CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection (3) (intro.) of s. 161.14, Stats., schedule I is amended to read:
CSB 2.006 Note (3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.006 Note (2) Paragraph (em) of sub. (3), s. 161.16, Stats., schedule II, is hereby created to read:
CSB 2.006 Note (em) Etorphine hydrochloride;
CSB 2.006 Note Note: See Chapter 206, Laws of 1981 sections 6, 20 and 24.
CSB 2.006 History History: Cr. Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.006 Note CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s. 161.16, Stats., schedule II is hereby created to read:
CSB 2.006 Note (d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.006 Note (2) Paragraph (n) of sub. (2) of s. 161.20, Stats., schedule IV is hereby created to read:
CSB 2.006 Note (n) Mebutamate
CSB 2.006 Note (3) Paragraph (b) of sub. (2m) of s. 161.20, Stats., schedule IV is hereby created to read:
CSB 2.006 Note (b) Pemoline:
CSB 2.006 Note Note: See Chapter 206, Laws of 1981 sections 20, 22 and 45.
CSB 2.006 History History: Cr. Register, February, 1976, No. 242, eff. 3-1-76.
CSB 2.006 Note CSB 2.09 Additions to schedules IV and I. (1)  Addition of benzodiazepine substances to schedule IV. Paragraphs (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s. 161.20, Stats., schedule IV are hereby created to read:
CSB 2.006 Note (cm) Chlordiazepoxide
CSB 2.006 Note (cn) Clonazepam
Loading...
Loading...
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.